Cells of the human intestinal tract mapped across space and time
Journal article
Elmentaite R. et al, (2021), Nature, 597, 250 - 255
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Journal article
Mlcochova P. et al, (2021), Nature
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Journal article
Wei J. et al, (2021), Nature Microbiology, 6, 1140 - 1149
Human and porcine transmission of Clostridioides difficile Ribotype 078, Europe
Journal article
Moloney G. et al, (2021), Emerging Infectious Diseases, 27, 2294 - 2300
Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006-2017.
Journal article
Kamau E. et al, (2021), Emerging infectious diseases, 27, 2261 - 2268
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Journal article
Pouwels KB. et al, (2021)
An end-to-end heterogeneous graph attention network for Mycobacterium tuberculosis drug-resistance prediction.
Journal article
Yang Y. et al, (2021), Briefings in bioinformatics
Biallelic PI4KA variants cause neurological, intestinal and immunological disease.
Journal article
Salter CG. et al, (2021), Brain : a journal of neurology
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil driven diseases
Journal article
Pavord ID. et al, (2021), Allergy
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Journal article
Skelly DT. et al, (2021), Nature communications, 12
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
Journal article
Bafadhel M. et al, (2021), Eur Respir J
The development of an intervention to support uptake and adherence to antiretroviral therapy in people living with HIV: the SUPA intervention. A brief report
Journal article
King K. et al, (2021), Translational Behavioral Medicine
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.
Journal article
Lamikanra A. et al, (2021), Transfusion
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
Journal article
Lumley SF. et al, (2021), Clinical Infectious Diseases, 73, e699 - e709
Generalizable characteristics of false-positive bacterial variant calls.
Journal article
Bush SJ., (2021), Microbial genomics, 7
Genomic network analysis of environmental and livestock F-type plasmid populations
Journal article
Matlock W. et al, (2021), The ISME Journal, 15, 2322 - 2335
Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
Journal article
Mokaya J. et al, (2021), Journal of Viral Hepatitis, 28, 1110 - 1120
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
Journal article
Pritchard E. et al, (2021), Nature medicine, 27, 1370 - 1378
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Yu L-M. et al, (2021), The Lancet
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485